trending Market Intelligence /marketintelligence/en/news-insights/trending/yWImQNIjCRSURPrBH1FOlQ2 content esgSubNav
In This List

Fennec Pharmaceuticals plans common stock offering

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Fennec Pharmaceuticals plans common stock offering

Fennec Pharmaceuticals Inc. plans to offer its common shares in an underwritten public offering.

The biotechnology company also plans to grant the underwriters an option to buy up to an additional 15% of the common shares offered.

Wedbush PacGrow is acting as the sole book-running manager for the proposed offering, while H.C. Wainwright & Co. is acting as the co-manager.